Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2022-08-31		NCT05334277

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Allist Pharmaceuticals, Inc.	15
GeneCast Biotechnology Co., Ltd.	9
Sun Yat-sen University	606

26 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital and Institute of Guangzhou Medical University	Guangzhou	China	6
Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang People's hospital	Dongyang	China	1
Affiliated Jinhua Hospital, Zhejiang University School of Medicine	Jinhua	China	1
Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute	Shenyang	China	1
Dongguan People's Hospital	Dongguan	China	12
Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University	Jiangmen	China	1
Mianyang Central Hospital	Mianyang	China	5
Nanfang Hospital, Southern Medical University	Guangzhou	China	15
Shijiazhuang People's hospital	Shijiazhuang	China	1
Sichuan Provincial People's Hospital	Chengdu	China	27
Sun Yat-Sen University Cancer Center	Guangzhou	China	66
Tangdu Hospital, Fourth Military Medical University	Xi'an	China	1
The Affiliated Cancer Hospital of Xinjiang Medical university	Ürümqi	China	5
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	21
The First Affiliated Hospital of Nanchang University	Nanchang	China	55
The First Affiliated Hospital of Xi'an Jiaotong University	Xi'an	China	39
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	61
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	13
The first affiliated hospital, Zhejiang university school of medicine	Hangzhou	China	27
The First Hospital of Jilin University	Changchun	China	33
The First People's Hospital of Foshan	Foshan	China	11
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	18
The Third Affiliated Hospital of Wenzhou Medical University, Rui'an People's Hospital	Wenzhou	China	1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37
Yijishan Hospital, Wannan Medical College	Wuhu	China	1

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Clinical trials

Organizations

Research sites